Sofinnova Investments, Inc. Novo Cure LTD Transaction History
Sofinnova Investments, Inc.
- $1.06 Billion
- Q3 2024
A detailed history of Sofinnova Investments, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 50,000 shares of NVCR stock, worth $1.23 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$1.23 Million% of portfolio
0.19%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
265Shares Held
76.5MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$297 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$290 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$194 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$106 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$74.3 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.57B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...